|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | |
| A61K 39/395 |
| (11) | Number of the document | 2437791 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10783933.4 |
| Date of filing the European patent application | 2010-06-01 | |
| (97) | Date of publication of the European application | 2012-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/036923 |
| Date | 2010-06-01 |
| (87) | Number | WO 2010/141483 |
| Date | 2010-12-09 |
| (30) | Number | Date | Country code |
| 182928 P | 2009-06-01 | US |
| (72) |
ZHU, Fu-Gang, US
KANDIMALLA, Ekambar, R., US
AGRAWAL, Sudhir, US
|
| (73) |
Idera Pharmaceuticals, Inc.,
167 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | POTENTIATION OF AUTOIMMUNE AND INFLAMMATORY DISEASE TREATMENTS BY IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) ANTAGONISTS OF TLR7 AND TLR9 |
| POTENTIATION OF AUTOIMMUNE AND INFLAMMATORY DISEASE TREATMENTS BY IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) ANTAGONISTS OF TLR7 AND TLR9 |